What Researchers Did
Researchers conducted a review of current treatment options for Lyme borreliosis.
What They Found
Prompt oral antimicrobial therapy, such as doxycycline or amoxicillin, successfully treats over 90% of patients with Lyme borreliosis. For severe or chronic infections, parenteral ceftriaxone is the preferred drug due to its good central nervous system penetration and high efficacy. However, a small minority of patients, less than 10%, do not respond to treatment.
Canadian Relevance
This review does not have a direct Canadian connection.
Study Limitations
As a review, this study is limited by its reliance on existing literature and the absence of clinical trial data for several adjunct therapies.